Publicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (15)

2024

  1. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

    British Journal of Surgery, Vol. 111, Núm. 3

2023

  1. DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities

    Cancers, Vol. 15, Núm. 2

  2. Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake

    Antioxidants, Vol. 12, Núm. 9

2020

  1. Cutaneous squamous cell carcinoma: From biology to therapy

    International Journal of Molecular Sciences, Vol. 21, Núm. 8

2016

  1. Genomic instability and early-onset colorectal cancer: a new form of classifying the disease?

    Annals of Oncology, Vol. 27, pp. vi185

2015

  1. Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach

    Genome Biology, Vol. 16, Núm. 1

2013

  1. The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: The retina 4 project

    Ophthalmology, Vol. 120, Núm. 3, pp. 623-628

2012

  1. Prevalence of autosomal recessive congenital ichthyosis: A population-based study using the capture-recapture method in Spain

    Journal of the American Academy of Dermatology, Vol. 67, Núm. 2, pp. 240-244

2010

  1. High-grade gliomas: epigenetic and genetic analysis

    EJC SUPPLEMENTS

  2. Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas

    BMC Cancer, Vol. 10

2006

  1. A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers

    Human Mutation, Vol. 27, Núm. 3, pp. 242-248

  2. BRCA1-2 mutations in breast cancer: Identification of nine new variants of BRCA1-2 genes in a population from central Western Spain

    Cancer Letters, Vol. 233, Núm. 1, pp. 172-177

2004

  1. Metástasis ovárica de cáncer de mama en mujer portadora de mutación en BRCA1

    Clinical and Translational Oncology, Vol. 6, Núm. 7, pp. 445-447

  2. The variant E233G of the rad51d gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations

    International Journal of Cancer, Vol. 110, Núm. 6, pp. 845-849

2003

  1. Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer

    International Journal of Cancer, Vol. 107, Núm. 5, pp. 781-790